|
|
|
Volumn 5, Issue 1, 2002, Pages 1-4
|
|
Report on the International Workshop on the Biopharmaceutics Classification System (BCS): Scientific and regulatory aspects in practice
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
ATENOLOL;
CIMETIDINE;
DODECYL SULFATE SODIUM;
DRUG;
EXCIPIENT;
FLUORESCEIN ISOTHIOCYANATE DEXTRAN;
FUROSEMIDE;
GENERIC DRUG;
HYDROCHLOROTHIAZIDE;
LACTOSE;
NEW DRUG;
NICOTINE;
PROPRANOLOL;
RANITIDINE;
SURFACTANT;
WATER;
ARTICLE;
BIOEQUIVALENCE;
CELL STRAIN CACO 2;
CONTROLLED STUDY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG CLASSIFICATION;
DRUG DISTRIBUTION;
DRUG DOSAGE FORM;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG FORMULATION;
DRUG INDICATION;
DRUG MANUFACTURE;
DRUG METABOLISM;
DRUG PENETRATION;
DRUG RELEASE;
DRUG SAFETY;
DRUG SOLUBILITY;
DRUG STRUCTURE;
FOOD DRUG INTERACTION;
GASTROINTESTINAL ABSORPTION;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INTESTINE TRANSIT TIME;
PARTITION COEFFICIENT;
PH;
PKA;
STOMACH EMPTYING;
ANIMALS;
BIOPHARMACEUTICS;
DRUG DELIVERY SYSTEMS;
DRUG EVALUATION;
GUIDELINES;
HUMANS;
PHARMACOKINETICS;
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;
RESEARCH;
SOLUBILITY;
THERAPEUTIC EQUIVALENCY;
|
|
EID: 0036240009
PISSN: 14821826
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (24)
|
|
References (0)
|
